These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 21424452)
1. Viruses as nanomaterials for drug delivery. Lockney D; Franzen S; Lommel S Methods Mol Biol; 2011; 726():207-21. PubMed ID: 21424452 [TBL] [Abstract][Full Text] [Related]
2. The Red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant viral nanoparticle. Lockney DM; Guenther RN; Loo L; Overton W; Antonelli R; Clark J; Hu M; Luft C; Lommel SA; Franzen S Bioconjug Chem; 2011 Jan; 22(1):67-73. PubMed ID: 21126069 [TBL] [Abstract][Full Text] [Related]
3. Controlled encapsidation of gold nanoparticles by a viral protein shell. Loo L; Guenther RH; Basnayake VR; Lommel SA; Franzen S J Am Chem Soc; 2006 Apr; 128(14):4502-3. PubMed ID: 16594649 [TBL] [Abstract][Full Text] [Related]
4. Encapsidation of nanoparticles by red clover necrotic mosaic virus. Loo L; Guenther RH; Lommel SA; Franzen S J Am Chem Soc; 2007 Sep; 129(36):11111-7. PubMed ID: 17705477 [TBL] [Abstract][Full Text] [Related]
5. Loading and release mechanism of red clover necrotic mosaic virus derived plant viral nanoparticles for drug delivery of doxorubicin. Cao J; Guenther RH; Sit TL; Opperman CH; Lommel SA; Willoughby JA Small; 2014 Dec; 10(24):5126-36. PubMed ID: 25098668 [TBL] [Abstract][Full Text] [Related]
6. Mass spectrometric detection of targeting peptide bioconjugation to Red clover necrotic mosaic virus. Wang R; Lockney DM; Goshe MB; Franzen S Bioconjug Chem; 2011 Oct; 22(10):1970-82. PubMed ID: 21854060 [TBL] [Abstract][Full Text] [Related]
7. Endoplasmic reticulum targeting of the Red clover necrotic mosaic virus movement protein is associated with the replication of viral RNA1 but not that of RNA2. Kaido M; Tsuno Y; Mise K; Okuno T Virology; 2009 Dec; 395(2):232-42. PubMed ID: 19819513 [TBL] [Abstract][Full Text] [Related]
8. Unique benefits of nanotechnology to drug delivery and diagnostics. McNeil SE Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949 [TBL] [Abstract][Full Text] [Related]
9. Toxicity of nanomaterials to the eye. Prow TW Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):317-33. PubMed ID: 20077524 [TBL] [Abstract][Full Text] [Related]
10. Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications. Hüser A; Hofmann C Am J Pharmacogenomics; 2003; 3(1):53-63. PubMed ID: 12562216 [TBL] [Abstract][Full Text] [Related]
11. The genomic RNA packaging scheme of Red clover necrotic mosaic virus. Basnayake VR; Sit TL; Lommel SA Virology; 2006 Feb; 345(2):532-9. PubMed ID: 16297955 [TBL] [Abstract][Full Text] [Related]
12. Plant Virus-Based Nanoparticles for the Delivery of Agronomic Compounds as a Suspension Concentrate. Guenther RH; Lommel SA; Opperman CH; Sit TL Methods Mol Biol; 2018; 1776():203-214. PubMed ID: 29869243 [TBL] [Abstract][Full Text] [Related]
13. Viral cell-to-cell movement requires formation of cortical punctate structures containing Red clover necrotic mosaic virus movement protein. Kaido M; Funatsu N; Tsuno Y; Mise K; Okuno T Virology; 2011 May; 413(2):205-15. PubMed ID: 21377183 [TBL] [Abstract][Full Text] [Related]
14. Copolymeric nanofilm platform for controlled and localized therapeutic delivery. Chow EK; Pierstorff E; Cheng G; Ho D ACS Nano; 2008 Jan; 2(1):33-40. PubMed ID: 19206545 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel polyglycerol hybrid nanomaterials for potential applications in drug delivery systems. Zarrabi A; Adeli M; Vossoughi M; Shokrgozar MA Macromol Biosci; 2011 Mar; 11(3):383-90. PubMed ID: 21108456 [TBL] [Abstract][Full Text] [Related]
17. Engineered nanoparticles as precise drug delivery systems. Yih TC; Al-Fandi M J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317 [TBL] [Abstract][Full Text] [Related]
18. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications. Son SJ; Bai X; Lee SB Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547 [TBL] [Abstract][Full Text] [Related]
19. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles. Liu Y; Franzen S Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455 [TBL] [Abstract][Full Text] [Related]
20. Imparting size, shape, and composition control of materials for nanomedicine. Euliss LE; DuPont JA; Gratton S; DeSimone J Chem Soc Rev; 2006 Nov; 35(11):1095-104. PubMed ID: 17057838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]